Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to -$1.3 million.

  • Biomerica's Income from Continuing Operations fell 3894.74% to -$1.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$4.0 million, marking a year-over-year increase of 2822.48%. This contributed to the annual value of -$5.0 million for FY2025, which is 1684.51% up from last year.
  • According to the latest figures from Q4 2025, Biomerica's Income from Continuing Operations is -$1.3 million, which was down 3894.74% from $2000.0 recorded in Q3 2025.
  • In the past 5 years, Biomerica's Income from Continuing Operations ranged from a high of $2000.0 in Q3 2025 and a low of -$2.1 million during Q1 2021
  • Over the past 5 years, Biomerica's median Income from Continuing Operations value was -$1.5 million (recorded in 2023), while the average stood at -$1.4 million.
  • In the last 5 years, Biomerica's Income from Continuing Operations plummeted by 148397.97% in 2023 and then surged by 10015.2% in 2025.
  • Quarter analysis of 5 years shows Biomerica's Income from Continuing Operations stood at -$1.1 million in 2021, then plummeted by 44.5% to -$1.6 million in 2022, then rose by 7.32% to -$1.5 million in 2023, then soared by 36.96% to -$950000.0 in 2024, then tumbled by 38.95% to -$1.3 million in 2025.
  • Its last three reported values are -$1.3 million in Q4 2025, $2000.0 for Q3 2025, and -$1.5 million during Q2 2025.